Oral Ketamine as a Practical, Low-Cost Option for Severe Depression
This educational prescriber's guide consolidates three decades of practice-based experience into a structured oral racemic ketamine protocol relevant to psychiatry and psychopharmacology pharmacists advising on off-label depression treatment.
Oral ketamine emerges as a safe, low-cost depression treatment.
Oral ketamine provides a noninvasive, cost-effective option for treating severe and treatment-resistant depression, particularly in low-resource settings. The guide outlines a protocol for safe administration of oral ketamine, emphasizing minimized side effects and its applicability in diverse clinical settings. This teaching article offers practical guidance for prescribers to use oral ketamine, highlighting drug interactions, dosing, and monitoring, critical for adoption in low- and middle-income countries. Oral ketamine is a viable, affordable option for depression, offering flexibility in treatment settings.
📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report.
Citation:Andrade C The Prescriber's Guide to Oral Ketamine for Patients With Major Depressive Illness: Principles and Practice. The Journal of clinical psychiatry. 2026;87(3). doi:10.4088/JCP.26f16110
Subscribers receive access to a complete clinical analysis, available online and as a downloadable PDF.
Executive Summary
Study Design
Patient Population
Primary Outcomes
Secondary Outcomes & Safety Profile
Pharmacist Implications
Clinical Pearls
Limitations
Controversies & Evidence Gaps
Cost & Logistics
Want the full analysis?
Subscribe to PharmD Signal for unrestricted access to every deep analysis, plus PDF reports, GRADE evidence grades, and pharmacist implications for every article we publish.